A carregar...

VP 16-213 in acute myelogenous leukaemia

The use of the epipodophyllotoxin VP 16-213 is described in twenty patients with acute myelogenous leukaemia resistant to other chemotherapy. The drug was usually given in 5-day courses of 50 mg/m(2) daily and occasionally in 24-hr infusions of 250 mg/m(2), on the basis of its phase-activity. Comple...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smith, I. E., Clink, H. MacD., Gerken, M. E., McElwain, T. J.
Formato: Artigo
Idioma:Inglês
Publicado em: 1976
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2496302/
https://ncbi.nlm.nih.gov/pubmed/772645
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!